SlideShare a Scribd company logo
Drug use in paediatric & geriatric
patients
Dr Shinde Viraj Ashok
Junior Resident – 2
Department of Pharmacology
GMC Nagpur
Guided by
Dr V. M. Motghare
Professor & Head
Dept of Pharmacology
GMC Nagpur
Dr S. Pimpalkhute
Lecturer
Dept of Pharmacology
GMC Nagpur
Introduction
• Pharmacokinetics
• Pharmacodynamics
• Calculation of drug dose
• Adverse drug reaction
• a
Drug use
in
paediatric
• Pharmacokinetics
• Pharmacodynamics
• Main drug groups
• Adverse drug reaction
• Special aspects of geriatric
pharmacology
Drug use
in
geriatric
• Infancy and childhood are rapid stages of
development , various organs, enzymes and body
systems that handle the drugs and dosage are
differ in time.
• Important changes in responses to some
drugs occur with increasing age in many
individuals. Among these changes are increased
incidence with advancing age of
 Several simultaneous diseases
 Nutritional problems
 Reduced financial sources
Drug use in paediatric & geriatric patients
Drug Absorption
1. Blood Flow at the Site of Administration
2. Gastrointestinal Function
3. Rectal absorption
4. Transdermal absorption
1. Blood Flow at the Site of Administration
• Absorption from IM or SC injection in neonates - rate of
blood flow to the muscle or subcutaneous area injected.
• Physiologic conditions - reduce blood flow
• Cardiovascular shock
• Vasoconstriction due to sympathomimetic agents
• Sick preterm infants - very little muscle mass.
Complicated by - diminished peripheral perfusion to these
areas.
• Examples of drugs especially hazardous in such situations
are
• Cardiac glycosides
• Aminoglycoside antibiotics
• Anticonvulsants
Infants Adults Elderly
Gastric pH High Normal[2 -3] High
Intestinal
surface area
Low More Low
Blood flow to
GIT
Low Normal Low
Enzyme activity Lower Normal Low
Bile acids &
Lipase
Low Normal Low
Absorption Altered pattern Normal Impaired
2. Gastrointestinal Function
3 Rectal absorption
• Faster & more predictable
• Diazepam solution is given rectally to control
febrile seizures in children < 5yrs
4 Transdermal absorption
• Faster
• Skin is thin & more permeable
Drug Distribution
• As body composition changes with development,
the distribution volumes of drugs are also
changed.
• Preterm infants (1% of total body weight) - less
fat than full-term infants (15% of total body
weight).
• Major factor determining drug distribution is
drug binding to plasma proteins.
• Albumin is the plasma protein with the
greatest binding capacity.
Drug Distribution
• Protein binding of drugs - reduced in the neonate.
• Local anaesthetic drugs
• Diazepam
• Phenytoin
• Ampicillin
• Phenobarbital
• Drugs given to a neonate with jaundice can displace
bilirubin from albumin. Because of the greater permeability
of the neonatal blood-brain barrier, substantial amounts of
bilirubin may enter the brain and cause kernicterus.
Example – sulfonamides
• Bilirubin can displace a drug from albumin - raise the free
drug concentration - would result in greater therapeutic
effect or toxicity at normal concentrations. Example-
phenytoin
Drug Metabolism
• Metabolism of most drugs occurs in the liver .
• Drug-metabolizing activities - cytochrome P450
dependent mixed-function oxidases and the
conjugating enzymes - 50% of adult values in
early neonatal life than later.
• Neonates decreased ability to metabolize drugs -
many drugs have slow clearance rates and
prolonged elimination half-lives.
• Example - Chloramphenicol can produce grey
baby syndrome
Comparison of elimination half-lives of
various drugs in neonates and adults.
Drug Metabolism
• If Mother has received drugs (eg phenobarbital) that can
induce early maturation of foetal hepatic enzymes.
• Ability of the neonate to metabolize certain drugs will be
greater than expected
• During toddlerhood - metabolic rate of many drugs
exceeds adult values, necessitating larger doses per
kilogram than later in life. Example – Theophylline ,
phenytoin & carbamazepine.
Less therapeutic effect
And
Lower plasma drug concentrations
Drug Excretion
Glomerular Filtration Rate
1. Lower in neonates born before 34 weeks of
gestation .
2. End of the third week – GFR is 50% of the
adult value.
3. By 6 -12 months – GFR reaches adult Values
(per unit surface area).
• Example – Gentamicin & penicillin t½ is prolonged
by 3 – 5 times
t1/2 of drugs is increased
• Drugs that depend on renal function for
elimination are cleared from the body very
slowly in the first weeks of life.
• During toddlerhood GFR exceeds adult values
Example - Digoxin
Larger doses per
kilogram than in
adults
Special Pharmacodynamic
Features in the Neonate
1. Administration of indomethacin - Rapid closure
of a patent ductus arteriosus
2. Infusion of prostaglandin E - Ductus to remain
open, which can be lifesaving in an infant with
transposition of the great vessels or tetralogy
of Fallot (caused antral hyperplasia with gastric
outlet obstruction)
3. Neonates - More sensitive to central
depressant effects of opioids than are older
children and adults - Necessitating extra
caution when they are exposed to some
narcotics (eg, codeine) through breast milk.
Elixirs Suspensions
Flavoured solutions of drug in sugar
syrup or glycerol along with higher
proportion of alcohol
Liquid medicament containing
insoluble substances which are
homogenously distributed
throughout vehicle with or
without help of suspending
agents.
Drug molecules are dissolved and evenly
distributed.
Undissolved particles and uneven
distribution
Shaking not required Shaking required
First dose from the bottle and the last
dose should contain equivalent amounts
of drug
First doses from the bottle may
contain less drug than the last
doses, with the result that less
than the expected plasma
concentration or effect of the
drug may be achieved early in the
course of therapy.
e.g. vit B -complex elixir, lanoxin elixir e.g. milk of magnesia, phenytoin
suspension
Reasons for non compliance
• Measuring errors
• Spilling
• Spitting out
• Discontinuation of antibiotics after feeling
better
How to check compliance ??
1. Random pill counts
2. Measurement of serum concentrations
3. Use of computerized pill containers
paediatric drug dose & its
calculation
1. Most reliable paediatric dose information - provided
by the manufacturer in the package insert.
2. In absence of explicit paediatric dose
recommendations , an approximation can be made by
methods based on age, weight or surface area.
3. Rules regarding this aren’t precise and should not
be used if the manufacturer provides a paediatric
dose.
4. When paediatric doses are calculated (either from
one of the methods set forth below or from a
manufacturers dose), the paediatric dose should
never exceed the adult dose.
Surface Area, Age, & Weight
• Calculations of dosage based on age or weight are
conservative and tend to underestimate the
required dose.
• Doses based on surface area are more likely to be
adequate.
Age (youngs formula)
Dose = Adult dose x Age(years)
Age+ 12
Determination of drug dosage from
surface area.
• Weight ( Clarks rule):
OR
Dose =Adult dose x Weight (kg)
70
Dose = Adult dose x Weight (lb)
150
Adverse drug reaction
Children are growing and are more susceptible to
adverse effects of drugs like
1. Corticosteroids – Suppression of growth
2. Androgens – Early fusion of epiphysis
( stunting of growth)
3. Tetracyclines - Discolouration & deformation
of teeth
4. Phenothiazines - Dystonic reactions
Drug use in paediatric &amp; geriatric patients
Duniya bhi ajab sara –e - faani dekhi
Har cheez yahaa'n ki aani jaani dekhi
Jo aa ke na jaaye wo budhaapa dekha
Jo jaa ke na aaye wo jawaani dekhi
Meer Babar Ali Anees
World is like a mortal motel
everything here is sure fatal (But)
saw never ending oldhood
and forever gone young puerile
Pharmacologic changes
Associated with aging
Pharmacokinetics
1. Absorption
Conditions associated with age that may alter the rate
of absorption of drugs -
1. Altered nutritional habits
2. Greater consumption of non prescription drugs
(eg, antacids and laxatives)
3. Changes in gastric emptying- slower in older persons
(older diabetics)
2. Distribution
Elderly have ( compared to young adults)
 Reduced lean body mass
 Reduced body water
 ↑ fat as a percentage of body mass
 ↓ serum albumin
 ↑ serum orosomucoid (a-acid glycoprotein)
 Loading dose - Alteration
 Maintenance dose - Reduced because of
reduced clearance of the drug.
Effect on plasma protein binding
Plasma protein binding reduced due to
 Reduction in plasma albumin levels
 Changes in binding affinity due to ageing.
Dose should be ↓ ↓
Drugs whose reduced protein binding in elderly
leads to adverse reactions
• Warfarin
• Diazepam
• Lorazepam
• Phenytoin
• Phenylbutazone
• Tolbutamide
Effects of Aging on Volume of Distribution
(Vd)
Aging Effect Vd Effect Examples
 body water  Vd for
hydrophilic drugs
ethanol, lithium
 lean body mass  Vd for for drugs
that bind to
muscle
digoxin
 fat stores  Vd for lipophilic
drugs
diazepam, trazodone
 plasma protein
(albumin)
 % of unbound or
free drug (active)
diazepam, valproic acid,
phenytoin, warfarin
 plasma protein
(1-acid glycoprotein)
 % of unbound or
free drug (active)
quinidine, propranolol,
erythromycin,
amitriptyline
• Examples:
Water soluble drugs like digoxin: in elderly the Vd of
digoxin is reduced so smaller dose in required to
provide adequate digitalization.
Lipid soluble drugs (lignocaine, thiopentone), Vd rises
leading to increased half life of a drug: increase drug
effect and toxicity. So dose should be reduced.
3. Metabolism
1. ↓ in hepatic microsomal drug metabolising
activity
2. ↓ hepatic blood flow
3. Heart failure - Alter the ability of the liver to
metabolize drugs - By Reducing hepatic blood
flow.
3. Elimination
• Age related decline of renal functional capacity is
very important
• Decline in creatinine clearance occurs in about two
thirds of the population.
• Serum creatinine alone is not an adequate measure
of renal function.
• Practical result
 Marked prolongation - half-life of many drugs eg -
atenolol, gabapentin, digoxin, quinolones, lithium,
aminoglycosides.
 Possibility of accumulation to toxic levels if dosage is
not reduced in size or frequency.
• Rough correction can be made by using
Patients from ages 40 through 80:
• For women, the result should be multiplied by
0.85 (because of reduced muscle mass).
Creatinine clearance (mL/min) = (140 -Age) x (Weight in kg)
72 xSerum creatinine in mg/dL
Lungs are important for the excretion of volatile
drugs.
 ↓ respiratory capacity
 ↑ incidence of active pulmonary disease in the elderly
Use of inhalation anaesthesia is less
common and parenteral agents more
common in this age group
Pharmacodynamic Changes
• It was long believed that geriatric patients were
much more sensitive to the action of many drugs,
implying a change in the pharmacodynamic interaction
of the drugs with their receptors
• Most apparent changes
 Altered pharmacokinetics
 Diminished homeostatic responses.
• Some data from animal studies suggest actual changes
with age in the characteristics or numbers of a few
receptors.
• The most extensive studies suggest a decrease in
responsiveness to ß-adrenoceptor agonists.
Diminished homeostatic responses are
1. Average blood pressure goes up - age
Incidence of symptomatic orthostatic hypotension
- Increases markedly.
2. Average 2- hour postprandial blood glucose level
increases - 1 mg/dL for each year of age above 50.
3. Temperature regulation – impaired
Hypothermia - Poorly tolerated by the elderly.
Behavioral & Lifestyle
Changes
Forgetting to take ones pills
Result of cognitive changes.
Cns drugs
Drugs to be avoided Reasons Safer alternatives
a) Sedatives & hypnotics –
antianxiety drugs
-Diazepam
-Barbiturates
-Clorazepate
-Prolongation of half life
-highly sensitive leading to
ataxia , loss of postural
reflex and fall
Oxazepam, lorazepam
–do not form active
metabolites
-have short half life
-less sedating
b)Analgesics
1)Opioids
Elderly very sensitive to
respiratory depressant
effects
Pentazocine be avoided
-Codeine ,
meperidine,
morphine.
-Titrate optimum
dose and frequency
of administration.
2)NSAIDs -Used very carefully may
cause GIT bleeding and
analgesic nephropathy
-Indomethacin avoided due
to CNS side effects.
-Ibuprofen ,
nimesulide
-Corticosteroids may
be used along with
calcium and Vit-D
supplements.
Cns drugs
Drugs to be avoided Reasons Safer alternatives
c)Antipsychotics
-Phenothiazine
analogues
-Haloperidol analogues
Avoided
-greater risk of
extrapyramidal side
effects and postural
hypotension
-Elderly very sensitive
to their anticholinergic
side effects
Thioridazine ,
olanzapine , risperidone
, ziprasidone are safe.
d) Antidepressants
-Tricyclic
antidepressants
-due to postural
hypotension &
anticholinergic side
effects
-SSRIs
-elimination not
affected with ageing.
e)Antimania
-Lithium
-Renal toxicity -carbamazepine or
valproic acid.
Cns drugs
Drugs to be avoided Reasons Safer alternatives
f) General
anaesthetics
-Halothane
-Thiopental
-more sensitive to
halothane more prone
to its hepatotoxicity
-very sensitive to
thiopental
-midazolam , propofol
-isoflurane -
expensive
g)Drugs for
Alzheimer’s disease
-Tacrine
-sensitive to CNS
toxicity having anti-
cholinergic effects
-hepatotoxicity
-Donepezil ,
memantine ,
galantamine are
preferred , being
safer.
CVS drugs
Drugs to be avoided Reasons Safer alternatives
a) Cardiac glycosides
-Digoxin
-increase sensitivity
to toxic
arrhythmogenic
actions of digoxin
-loading
dose=reduced
-maintenance
dose=reduced.
b) Antiarrhythmic
drugs
-Disopyramide
-Quinidine
-Quinidine clearance
decreased and half
life prolonged
-Disopyramide
avoided =its anti-
muscarinic effects
-dose must be
reduced.
c) Platelete inhibitors
-Dipyridamole
-postural
hypotension,
coronary steal
-clopidogrel or
aspirin
Antihypertensive Drugs
1. Hypertension - Treated vigorously in the elderly.
2. Thiazides - First step in drug therapy
3. Hypokalemia , hyperglycemia, and hyperuricemia
caused by these agents are more relevant in the elderly
because of the higher incidence in these patients of
arrhythmias, type 2 diabetes, and gout.
4. Calcium channel blockers –
Effective and safe if titrated to the appropriate
response
Useful in patients who also have atherosclerotic
angina.
5. Beta blockers - potentially hazardous in patients with
obstructive airway disease
- considered less useful than calcium channel blockers
in older patients unless heart Failure is present.
Drugs for Respiratory Diseases
Drugs to be avoided Reasons Safer alternatives
-Ephedrine
-Isoproterenol
-Theophylline
-high BP, tachycardia
-tremors
-CNS stimulants
-Salbutamol ,
beclomethasone
Antibiotics
Drugs to be avoided Reasons Safer alternatives
-Penicillins
-Cephalosporins
-Fluoroquinolones
-decline in renal
function
-sensitive to
peripheral neuritis
-Ceftriaxone or
cefoperazone
excreted through bile
Anti-diabetic drugs
Drugs to be avoided Reasons Safer alternatives
-Chlorpropamide
-Glibenclamide
-half lives increased
in elderly
-serious
hypoglycaemic
episodes
-fluid retention
-Glipizide , gliclazide
And natiglinide +
metformin may be
used
Adverse drug reactions in elderly
• Single drug – 10 % chances of ADR
Ten drug – nearly 100 % chances of ADR
• Patients may see several different practitioners
for different conditions and accumulate multiple
prescriptions for drugs with overlapping actions.
• Reasons for high incidence of ADR include
• Errors in prescribing on the part of the practitioner.
• Errors in drug usage by the patient.
Adverse drug reactions elderly
• It is useful to Conduct a brown bag analysis in such
patients.
• Brown bag analysis consists of asking the patient
to bring to the practitioner a bag containing all
the medications, supplements, vitamins, etc, that
he or she is currently taking
Practical aspects of
geriatric pharmacology
• Quality of life in elderly patients can be greatly
improved and life span can be prolonged by the
intelligent use of drugs.
• Expense of drugs can be a major disincentive in
patients receiving marginal retirement incomes
who are not covered or inadequately covered by
health insurance.
• Nonadherence may result from forgetfulness or
confusion, especially if the patient has several
prescriptions and different dosing intervals.
Practical aspects of
geriatric pharmacology
• Prescriptions written by several Different
practitioners - no attempt to design integrated
regimens that use drugs with similar dosing
Intervals for the conditions being treated.
• Non adherence may also be deliberate. A decision
not to take a drug may be based on prior
experience with it.
Errors in drug taking are caused by physical
disabilities.
1. Arthritis
2. Tremor
3. Visual problems may all contribute.
4. Liquid medications that are to be measured by
the spoonful are especially inappropriate for
patients with any type of tremor or motor
disability.
Practical aspects of
geriatric pharmacology
• Cataracts and macular degeneration occur in a large
number of patients over 70
 Labels on prescription bottles should be large
enough for the patient with diminished vision to
read
or
 Colour coded if the patient can see but can no
longer read
Practical aspects of
geriatric pharmacology
Drug therapy has considerable potential for both
helpful and harmful effects in the geriatric patient.
The balance may be tipped in the right direction by
adherence to a few principles:
1. Take a careful drug history.
2. Prescribe only for a specific and rational indication.
Do not prescribe omeprazole for dyspepsia.
3. Define - Goal of drug therapy.
4. Maintain a high index of suspicion regarding drug
reactions and interactions.
5. Simplify the regimen as much as possible.
Conclusion
Special caution should be taken while prescribing to
paediatric and elderly age group taking in to
consideration their altered pharmacokinetic and
pharmacodynamics parameters
Elderly patients are generally taking medicines for
two or three associated chronic diseases (hypertension,
diabetes , psychiatric illness etc) possibility of drug
drug interaction should be given due attention while
prescribing to them.
Paediatric patients should not be treated as if
they are mini adults ( simply modifying dose using body
weight or surface area formula is not sufficient).
References
• Katzungs basic & clinical pharmacology 12th
edition
• Principle of pharmacology ,S.K Sharma 2nd edition
• Pharmacology & pharmacotherapeutics, Satoskar
23rd edition
Drug use in paediatric &amp; geriatric patients
B. Gastrointestinal Function
• In full-term infants, gastric acid secretion begins soon after birth and
increases gradually over Several hours.
• In preterm infants, the secretion of gastric acid occurs more slowly, with
the highest concentrations appearing on the fourth day of life. Therefore,
drugs that are usually partially or totally inactivated by the low pH of
gastric contents should not be administered orally.
• Gastric emptying time is prolonged (up to 6 or 8 hours) in the first day or so
after delivery - drugs absorbed primarily in stomach may be absorbed more
completely than anticipated.
• Drugs absorbed in the small intestine, therapeutic effect may be delayed
• amount of drug absorbed in the small intestine - unpredictable; .
Peristalsis in the neonate is irregular and may be slow.
• more than the usual amount of drug may be absorbed if peristalsis is
slowed, and this could result in potential toxicity from an otherwise
standard dose.
• An increase in peristalsis, as in diarrheal conditions,
tends to decrease the extent of absorption, because
contact time with the large absorptive surface of
the intestine is decreased.
• Gastrointestinal enzyme activities - lower in the
newborn than in the adult.
• Activities of a-amylase and other pancreatic
enzymes in the duodenum are Low in infants up to 4
months Of age.
• Neonates low concentrations of bile acids and lipase
-decrease the absorption of lipid-soluble drugs.
Paediatric dosage forms &
compliance
• Elixirs - alcoholic solutions - drug molecules are
dissolved and evenly distributed. No shaking is required,
and unless some of the vehicle has evaporated , the first
dose from the bottle and the last dose should contain
equivalent amounts of drug.
• Suspensions - undissolved particles of drug that must
be distributed throughout the vehicle by shaking.
If shaking is not thorough each time a
dose is given , the first doses from the bottle may contain
less drug than the last doses, with the result that less than
the expected plasma concentration or effect of the drug
may be achieved early in the course of therapy.
Conversely, Toxicity may occur late in the
course of therapy , when it is not expected.
• Uneven distribution is a potential cause of inefficacy or
toxicity in children taking phenytoin suspensions .
• Compliance may be more difficult to achieve in paediatric
practice than otherwise, since it involves not only the
parents conscientious effort to follow directions but also
such practical matters as measuring errors , spilling, and
spitting out. For example, the measured Volume of
teaspoons ranges from2.5 to 7.8 mL .
• Parents should obtain a calibrated medicine spoon or
syringe from the pharmacy. These devices improve the
accuracy of dose measurements and simplify administration
of drugs to children.
• Parents may not always be able to say with confidence how much of a
dose the child actually received.
• Parents must be told whether or not to wake the infant for its every-
6-hour dose day or night.
• Matters should be discussed and made clear, and no assumptions
should be made about what the parents may or may not do
• Noncompliance frequently occurs when antibiotics are prescribed to
treat otitis media or urinary tract infections and the child feels well
after 4 or 5 days of therapy.
• Parents may not feel there is any reason to continue giving the
medicine even though it was prescribed for 10 or 14 days. This
common situation should be anticipated so the parents can be told
why it is important to continue giving the medicine for the prescribed
period even if the child seems to be cured.・
• Practical and convenient dosage forms and dosing
schedules should be chosen to the extent possible.
• Whenever a drug does not achieve its therapeutic
effect, the possibility of noncompliance should be
considered.
Challenges of Geriatric Pharmacotherapy
• New drugs available each year
• Advanced understanding of drug-drug
interactions
• Multiple co-morbid states
• Polypharmacy
• Medication compliance
• Effects of aging physiology on drug therapy
• Medication cost
Some potential strategies for the
prevention or treatment of Alzheimer’s
disease.
Major drug groups
CENTRAL NERVOUS SYSTEM DRUGS
Sedatives & hypnotics
• Half lives of many benzodiazepines and
barbiturates increase by 50 - 150% between ages
30 and 70 change occurs during the decade from
60 to 70.
• Toxicities of these drugs, ataxia and other signs
of motor impairment should be particularly
watched for in order to avoid accidents.
Analgesics
• Opioid analgesics show variable changes in
pharmacokinetics
with age.
• Elderly - more sensitive to respiratory effects of
these agents because of age-related changes in
respiratory function.
Antipsychotic & Antidepressant Drugs
• Traditional antipsychotic agents
(phenothiazines and haloperidol) Have
been very heavily used (and probably
misused) in the management of a variety
of psychiatric diseases in the elderly.
Drugs Used in Alzheimer’s Disease
• Memantine binds to NMDA receptor channels in a
use-dependent manner and produces a non competitive
blockade.
• Drug appears to be better tolerated and less Toxic
than the cholinesterase inhibitors.
• Memantine is available As Namenda in 5 and 10 mg
oral tablets.
• Positive Inotropic Agents
1. Heart failure is a common and particularly lethal
disease in the elderly.
2. Toxic effects of digoxin - dangerous in the geriatric
population- elderly are more susceptible to
arrhythmias.
3. Because the drug is cleared mostly by the kidneys,
renal function must be considered in designing a
dosage regimen.
4. Hypokalemia, hypomagnesemia, hypoxemia (from
pulmonary disease), and coronary atherosclerosis all
contribute to the high incidence of digitalis-induced
arrhythmias in geriatric patients.
Antiarrhythmic Agents
1. Treatment of arrhythmias in the elderly is challenging
because of the lack of good hemodynamic reserve.
2. The Frequency of electrolyte disturbances, and the high
prevalence Of Severe coronary disease.
3. Clearances of quinidine and procainamide decrease and
their half-lives increase with age.
4. Disopyramide should probably be avoided in the geriatric
population because its major toxicities antimuscarinic
action,
1. leading to voiding problems in men
2. negative inotropic cardiac effects, leading to heart failure
5. Measures (such as anticoagulant drugs) should be taken
to reduce the risk of thromboembolism in chronic atrial
fibrillation.
Antimicrobial drugs
• Age-related changes contribute to the high incidence of
infections in geriatric patients.
• In lungs, a major age and tobacco dependent decrease in
mucociliary clearance significantly increases susceptibility
to infection.
• In urinary tract, the incidence of serious infection is
greatly increased by urinary retention and catheterization
in men.
• Decreased renal function; because most of the ß-lactam,
aminoglycoside, and fluoroquinolone antibiotics are
excreted by this route, important changes in half-life may
be expected.
• Aminoglycosides cause concentration- and time-dependent
toxicity in the kidney and in other organs.
Anti-inflammatory drugs
• Osteoarthritis is a very common disease of the
elderly.
• Nonsteroidal anti-inflammatory agents (NSAIDs) -
used with special care in geriatric patients because
they cause toxicities to which the elderly are very
susceptible.
• Aspirin - gastrointestinal irritation and bleeding.
• Newer NSAIDs - renal damage may be irreversible.
• Corticosteroids are extremely useful in elderly
patients who cannot tolerate full doses of NSAIDs -
but they consistently cause a dose- and duration-
related increase in osteoporosis.
Ophthalmic drugs
Macular Degeneration
• Age-related macular degeneration (AMD) is the most
common cause of blindness in the elderly in the
developed world.
Drug use in paediatric &amp; geriatric patients
Drug use in paediatric &amp; geriatric patients
Drug use in paediatric &amp; geriatric patients
Drug use in paediatric &amp; geriatric patients
Drug use in paediatric &amp; geriatric patients
Drug use in paediatric &amp; geriatric patients
Drug use in paediatric &amp; geriatric patients
Drug use in paediatric &amp; geriatric patients

More Related Content

PPTX
Drug therapy in pediatric and geriatric age groups
Naser Tadvi
 
PPTX
Pharmacovigilance programme of india
chandan kumar
 
PPTX
Drug therapy in geriatrics
PHARMA IQ EDUCATION
 
PPTX
Nerve injury
Cathrine Diana
 
PPTX
Drug receptor interactions and types of receptor
Dr. Siddhartha Dutta
 
PPTX
Medication during pregnancy
Mohammad Alauddin
 
PPTX
Drug therapy in children
NiveditaMishra17
 
PPTX
Alternative to animal toxicit testing.pptx
ANANYAPANDEY71
 
Drug therapy in pediatric and geriatric age groups
Naser Tadvi
 
Pharmacovigilance programme of india
chandan kumar
 
Drug therapy in geriatrics
PHARMA IQ EDUCATION
 
Nerve injury
Cathrine Diana
 
Drug receptor interactions and types of receptor
Dr. Siddhartha Dutta
 
Medication during pregnancy
Mohammad Alauddin
 
Drug therapy in children
NiveditaMishra17
 
Alternative to animal toxicit testing.pptx
ANANYAPANDEY71
 

What's hot (20)

PPTX
Drugs used in special age groups like children, elderly and preganancy
Roopali Somani
 
PPTX
Pediatrics, Geriatrics, Pregnancy, Lactation
BikashAdhikari26
 
PPTX
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Anjali Rarichan
 
PPTX
Dosing in obese patient
Dr. Ramesh Bhandari
 
PPT
Clinical pharmacy
Sitaram Khadka
 
PPTX
introduction to Pharmacoepidemiology
aiswarya thomas
 
PPTX
Rational use of medicine
Muhammad Arsal
 
DOCX
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
pavithra vinayak
 
PPTX
Drug Information Centre
varshawadnere
 
DOCX
Clinical pharmacokinetics and its application
pavithra vinayak
 
PPTX
adverse drug reactions management
pharmacologyseminars
 
PPTX
Medication history interview
Rafi Bhat
 
PPTX
Rational use of otc medication
Rafi Bhat
 
PPT
Drug information final
Sitaram Khadka
 
PPT
Detection, reporting and management of adverse events
Katla Swapna
 
PPT
INTRODUCTION OF CLINICAL PHARMACY
Venkata subbareddy Bareddy
 
PPTX
pharmacokinetic drug interactions
Syed Imran
 
PPTX
Unit 1 pharmacoepidemiology
Dr. Supriya Suman
 
PPTX
Pharmacodynamic interactions
Mash'hood Mahmood Khan Shahid
 
PPT
Spontaneous reporting
Madhuri Miriyala
 
Drugs used in special age groups like children, elderly and preganancy
Roopali Somani
 
Pediatrics, Geriatrics, Pregnancy, Lactation
BikashAdhikari26
 
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Anjali Rarichan
 
Dosing in obese patient
Dr. Ramesh Bhandari
 
Clinical pharmacy
Sitaram Khadka
 
introduction to Pharmacoepidemiology
aiswarya thomas
 
Rational use of medicine
Muhammad Arsal
 
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
pavithra vinayak
 
Drug Information Centre
varshawadnere
 
Clinical pharmacokinetics and its application
pavithra vinayak
 
adverse drug reactions management
pharmacologyseminars
 
Medication history interview
Rafi Bhat
 
Rational use of otc medication
Rafi Bhat
 
Drug information final
Sitaram Khadka
 
Detection, reporting and management of adverse events
Katla Swapna
 
INTRODUCTION OF CLINICAL PHARMACY
Venkata subbareddy Bareddy
 
pharmacokinetic drug interactions
Syed Imran
 
Unit 1 pharmacoepidemiology
Dr. Supriya Suman
 
Pharmacodynamic interactions
Mash'hood Mahmood Khan Shahid
 
Spontaneous reporting
Madhuri Miriyala
 
Ad

Similar to Drug use in paediatric &amp; geriatric patients (20)

PPTX
Geriatric & Paediatric pharmacology 1.pptx
kavyanshiverma75
 
PPTX
Paediatric Pharmacology Part-2.pptx
65NidheeshKumarPraba
 
PPTX
Paediatrics
Virendra Neve
 
PPTX
prescribing in paediatrics.pptx
AraphaMvugalo
 
PPTX
7 Principles of pediatric pharmacotherapy.pptx
Sani191640
 
PPT
Factors modifying drug actions & effects
Eneutron
 
PPTX
Paediatric pharmaco-kinetics
Ahmad K
 
PDF
TDM POINTERS [GERIATIC & PAEDIATRIC PATIENTS].pdf
samthamby79
 
PPTX
Neonatal pediatric-pharmacology
dunya
 
PPTX
POSOLOGY.pptx
Venugopal N
 
PPT
Factors that you need to consider affecting drug action .ppt
AdugnaWari
 
PPTX
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
kavitharaninachiya
 
PPTX
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Azad Haleem
 
PPT
Clinical pharmacology in special populations 2014
vanessawhitehawk
 
PPTX
PK and Drug Therapy in pediatrics, geriatrics and pregnancy & Lactation
Sreeja Saladi
 
PPTX
Geriatric & Pediatrics Pharmacology
Manoj Kumar
 
PPTX
Factors affecting drug action in Pharmacology
Amol Deore
 
PPTX
Analgesic in Pedo-Part 1.pptx
Dr.Vani Bais
 
PPT
Clinical pharmacy age factors : Features of the Rational use of Medicines
Eneutron
 
Geriatric & Paediatric pharmacology 1.pptx
kavyanshiverma75
 
Paediatric Pharmacology Part-2.pptx
65NidheeshKumarPraba
 
Paediatrics
Virendra Neve
 
prescribing in paediatrics.pptx
AraphaMvugalo
 
7 Principles of pediatric pharmacotherapy.pptx
Sani191640
 
Factors modifying drug actions & effects
Eneutron
 
Paediatric pharmaco-kinetics
Ahmad K
 
TDM POINTERS [GERIATIC & PAEDIATRIC PATIENTS].pdf
samthamby79
 
Neonatal pediatric-pharmacology
dunya
 
POSOLOGY.pptx
Venugopal N
 
Factors that you need to consider affecting drug action .ppt
AdugnaWari
 
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
kavitharaninachiya
 
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Azad Haleem
 
Clinical pharmacology in special populations 2014
vanessawhitehawk
 
PK and Drug Therapy in pediatrics, geriatrics and pregnancy & Lactation
Sreeja Saladi
 
Geriatric & Pediatrics Pharmacology
Manoj Kumar
 
Factors affecting drug action in Pharmacology
Amol Deore
 
Analgesic in Pedo-Part 1.pptx
Dr.Vani Bais
 
Clinical pharmacy age factors : Features of the Rational use of Medicines
Eneutron
 
Ad

More from Viraj Shinde (20)

PPTX
Vasoactive peptides
Viraj Shinde
 
PPTX
pharmacotherapy of Uti
Viraj Shinde
 
PPTX
Sympathomimetic
Viraj Shinde
 
PPTX
Ruxolitinib
Viraj Shinde
 
PPTX
Rheumatoid arthritis
Viraj Shinde
 
PPTX
Revocation , restoration of patent and compulsory licenses
Viraj Shinde
 
PPTX
Recent advances in diabetic gastroparesis
Viraj Shinde
 
PPTX
Pharmacology of female sex hormones
Viraj Shinde
 
PPTX
Pharmacogenomics
Viraj Shinde
 
PPTX
Local anesthetics and counter irritants
Viraj Shinde
 
PPTX
Insulin sensitizers
Viraj Shinde
 
PPTX
Haematopoetic agents
Viraj Shinde
 
PPTX
Essential medicine concepts
Viraj Shinde
 
PPTX
Empagliflozin
Viraj Shinde
 
PPTX
Em antidiabetic drugs
Viraj Shinde
 
PPTX
Distribution of drugs
Viraj Shinde
 
PPTX
Clinical case discussion.pptx diabetic ketoacidosis
Viraj Shinde
 
PPTX
Clinical case discussion- inferior wall MI
Viraj Shinde
 
PPTX
Clinical case discussion - myasthenia gravis
Viraj Shinde
 
PPTX
Apremilast
Viraj Shinde
 
Vasoactive peptides
Viraj Shinde
 
pharmacotherapy of Uti
Viraj Shinde
 
Sympathomimetic
Viraj Shinde
 
Ruxolitinib
Viraj Shinde
 
Rheumatoid arthritis
Viraj Shinde
 
Revocation , restoration of patent and compulsory licenses
Viraj Shinde
 
Recent advances in diabetic gastroparesis
Viraj Shinde
 
Pharmacology of female sex hormones
Viraj Shinde
 
Pharmacogenomics
Viraj Shinde
 
Local anesthetics and counter irritants
Viraj Shinde
 
Insulin sensitizers
Viraj Shinde
 
Haematopoetic agents
Viraj Shinde
 
Essential medicine concepts
Viraj Shinde
 
Empagliflozin
Viraj Shinde
 
Em antidiabetic drugs
Viraj Shinde
 
Distribution of drugs
Viraj Shinde
 
Clinical case discussion.pptx diabetic ketoacidosis
Viraj Shinde
 
Clinical case discussion- inferior wall MI
Viraj Shinde
 
Clinical case discussion - myasthenia gravis
Viraj Shinde
 
Apremilast
Viraj Shinde
 

Recently uploaded (20)

DOCX
RUHS II MBBS Pharmacology Paper-I with Answer Key | 26 July 2025 (New Scheme)
Shivankan Kakkar
 
PPTX
BRAIN DEATH- DIAGNOSIS, MANAGEMENT AND LEGAL ISSUES - Dr. Vaidyanathan R .pptx
Dr.Vaidyanathan R
 
PDF
Chronic pelvic pain gynecology slides.pdf
alifaisal9338
 
PPTX
Ultrasound Machine - knobology-Dr. Vaidyanathan R.pptx
Dr.Vaidyanathan R
 
PPTX
Slider: TOC sampling methods for cleaning validation
Markus Janssen
 
PDF
Histology of Nose & paranasal sinuses - Dr Muhammad Ali Rabbani
MedicoseAcademics
 
PPTX
CLABSI-CAUTI (CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS & CATHETER ASSO...
Dr.Vaidyanathan R
 
PPTX
LARYNX CANCER 5.pptx,presentation,signs and symptoms
Latha Sukumar Dasi
 
PPTX
Optimal sites for mini-implant insertion into the infrazygomatic crest accord...
Dr Anurag JB
 
PPTX
CANSA Womens Health UTERINE focus Top Cancers slidedeck Aug 2025
CANSA The Cancer Association of South Africa
 
PPTX
INFLAMMATION
Soumyadip Datta
 
PDF
NEET PG-2023 Expected questions and topics
Abhishek107368
 
DOCX
RUHS II MBBS Pharmacology Paper-II with Answer Key | 28 July 2025 (New Scheme)
Shivankan Kakkar
 
PPTX
Anaesthesia Machine - Safety Features and Recent Advances - Dr.Vaidyanathan R
VAIDYANATHAN R
 
PDF
CT Anatomy for Radiotherapy.pdf eryuioooop
DrHabtamu1
 
PPTX
4. Basic Principles managment of dislocation.pptx
orthojju
 
PDF
Solution of Psycho ED: Best Sexologist in Patna, Bihar India Dr. Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
 
PPTX
ALBUMIN-The Comeback colloid- Dr.Vaidyanathan R
Dr.Vaidyanathan R
 
PPTX
1.2) Congestive Cardiac Failure.pptx Cardiovascular disease
Dr. Sarita Sharma
 
PPTX
Anatomy of eyelids basic anatomy covered along with abnormalities of eyelids
SummyBhatnagar1
 
RUHS II MBBS Pharmacology Paper-I with Answer Key | 26 July 2025 (New Scheme)
Shivankan Kakkar
 
BRAIN DEATH- DIAGNOSIS, MANAGEMENT AND LEGAL ISSUES - Dr. Vaidyanathan R .pptx
Dr.Vaidyanathan R
 
Chronic pelvic pain gynecology slides.pdf
alifaisal9338
 
Ultrasound Machine - knobology-Dr. Vaidyanathan R.pptx
Dr.Vaidyanathan R
 
Slider: TOC sampling methods for cleaning validation
Markus Janssen
 
Histology of Nose & paranasal sinuses - Dr Muhammad Ali Rabbani
MedicoseAcademics
 
CLABSI-CAUTI (CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS & CATHETER ASSO...
Dr.Vaidyanathan R
 
LARYNX CANCER 5.pptx,presentation,signs and symptoms
Latha Sukumar Dasi
 
Optimal sites for mini-implant insertion into the infrazygomatic crest accord...
Dr Anurag JB
 
CANSA Womens Health UTERINE focus Top Cancers slidedeck Aug 2025
CANSA The Cancer Association of South Africa
 
INFLAMMATION
Soumyadip Datta
 
NEET PG-2023 Expected questions and topics
Abhishek107368
 
RUHS II MBBS Pharmacology Paper-II with Answer Key | 28 July 2025 (New Scheme)
Shivankan Kakkar
 
Anaesthesia Machine - Safety Features and Recent Advances - Dr.Vaidyanathan R
VAIDYANATHAN R
 
CT Anatomy for Radiotherapy.pdf eryuioooop
DrHabtamu1
 
4. Basic Principles managment of dislocation.pptx
orthojju
 
Solution of Psycho ED: Best Sexologist in Patna, Bihar India Dr. Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
 
ALBUMIN-The Comeback colloid- Dr.Vaidyanathan R
Dr.Vaidyanathan R
 
1.2) Congestive Cardiac Failure.pptx Cardiovascular disease
Dr. Sarita Sharma
 
Anatomy of eyelids basic anatomy covered along with abnormalities of eyelids
SummyBhatnagar1
 

Drug use in paediatric &amp; geriatric patients

  • 1. Drug use in paediatric & geriatric patients Dr Shinde Viraj Ashok Junior Resident – 2 Department of Pharmacology GMC Nagpur Guided by Dr V. M. Motghare Professor & Head Dept of Pharmacology GMC Nagpur Dr S. Pimpalkhute Lecturer Dept of Pharmacology GMC Nagpur
  • 2. Introduction • Pharmacokinetics • Pharmacodynamics • Calculation of drug dose • Adverse drug reaction • a Drug use in paediatric • Pharmacokinetics • Pharmacodynamics • Main drug groups • Adverse drug reaction • Special aspects of geriatric pharmacology Drug use in geriatric
  • 3. • Infancy and childhood are rapid stages of development , various organs, enzymes and body systems that handle the drugs and dosage are differ in time. • Important changes in responses to some drugs occur with increasing age in many individuals. Among these changes are increased incidence with advancing age of  Several simultaneous diseases  Nutritional problems  Reduced financial sources
  • 5. Drug Absorption 1. Blood Flow at the Site of Administration 2. Gastrointestinal Function 3. Rectal absorption 4. Transdermal absorption
  • 6. 1. Blood Flow at the Site of Administration • Absorption from IM or SC injection in neonates - rate of blood flow to the muscle or subcutaneous area injected. • Physiologic conditions - reduce blood flow • Cardiovascular shock • Vasoconstriction due to sympathomimetic agents • Sick preterm infants - very little muscle mass. Complicated by - diminished peripheral perfusion to these areas. • Examples of drugs especially hazardous in such situations are • Cardiac glycosides • Aminoglycoside antibiotics • Anticonvulsants
  • 7. Infants Adults Elderly Gastric pH High Normal[2 -3] High Intestinal surface area Low More Low Blood flow to GIT Low Normal Low Enzyme activity Lower Normal Low Bile acids & Lipase Low Normal Low Absorption Altered pattern Normal Impaired 2. Gastrointestinal Function
  • 8. 3 Rectal absorption • Faster & more predictable • Diazepam solution is given rectally to control febrile seizures in children < 5yrs 4 Transdermal absorption • Faster • Skin is thin & more permeable
  • 9. Drug Distribution • As body composition changes with development, the distribution volumes of drugs are also changed. • Preterm infants (1% of total body weight) - less fat than full-term infants (15% of total body weight). • Major factor determining drug distribution is drug binding to plasma proteins. • Albumin is the plasma protein with the greatest binding capacity.
  • 10. Drug Distribution • Protein binding of drugs - reduced in the neonate. • Local anaesthetic drugs • Diazepam • Phenytoin • Ampicillin • Phenobarbital • Drugs given to a neonate with jaundice can displace bilirubin from albumin. Because of the greater permeability of the neonatal blood-brain barrier, substantial amounts of bilirubin may enter the brain and cause kernicterus. Example – sulfonamides • Bilirubin can displace a drug from albumin - raise the free drug concentration - would result in greater therapeutic effect or toxicity at normal concentrations. Example- phenytoin
  • 11. Drug Metabolism • Metabolism of most drugs occurs in the liver . • Drug-metabolizing activities - cytochrome P450 dependent mixed-function oxidases and the conjugating enzymes - 50% of adult values in early neonatal life than later. • Neonates decreased ability to metabolize drugs - many drugs have slow clearance rates and prolonged elimination half-lives. • Example - Chloramphenicol can produce grey baby syndrome
  • 12. Comparison of elimination half-lives of various drugs in neonates and adults.
  • 13. Drug Metabolism • If Mother has received drugs (eg phenobarbital) that can induce early maturation of foetal hepatic enzymes. • Ability of the neonate to metabolize certain drugs will be greater than expected • During toddlerhood - metabolic rate of many drugs exceeds adult values, necessitating larger doses per kilogram than later in life. Example – Theophylline , phenytoin & carbamazepine. Less therapeutic effect And Lower plasma drug concentrations
  • 14. Drug Excretion Glomerular Filtration Rate 1. Lower in neonates born before 34 weeks of gestation . 2. End of the third week – GFR is 50% of the adult value. 3. By 6 -12 months – GFR reaches adult Values (per unit surface area). • Example – Gentamicin & penicillin t½ is prolonged by 3 – 5 times t1/2 of drugs is increased
  • 15. • Drugs that depend on renal function for elimination are cleared from the body very slowly in the first weeks of life. • During toddlerhood GFR exceeds adult values Example - Digoxin Larger doses per kilogram than in adults
  • 16. Special Pharmacodynamic Features in the Neonate 1. Administration of indomethacin - Rapid closure of a patent ductus arteriosus 2. Infusion of prostaglandin E - Ductus to remain open, which can be lifesaving in an infant with transposition of the great vessels or tetralogy of Fallot (caused antral hyperplasia with gastric outlet obstruction) 3. Neonates - More sensitive to central depressant effects of opioids than are older children and adults - Necessitating extra caution when they are exposed to some narcotics (eg, codeine) through breast milk.
  • 17. Elixirs Suspensions Flavoured solutions of drug in sugar syrup or glycerol along with higher proportion of alcohol Liquid medicament containing insoluble substances which are homogenously distributed throughout vehicle with or without help of suspending agents. Drug molecules are dissolved and evenly distributed. Undissolved particles and uneven distribution Shaking not required Shaking required First dose from the bottle and the last dose should contain equivalent amounts of drug First doses from the bottle may contain less drug than the last doses, with the result that less than the expected plasma concentration or effect of the drug may be achieved early in the course of therapy. e.g. vit B -complex elixir, lanoxin elixir e.g. milk of magnesia, phenytoin suspension
  • 18. Reasons for non compliance • Measuring errors • Spilling • Spitting out • Discontinuation of antibiotics after feeling better
  • 19. How to check compliance ?? 1. Random pill counts 2. Measurement of serum concentrations 3. Use of computerized pill containers
  • 20. paediatric drug dose & its calculation 1. Most reliable paediatric dose information - provided by the manufacturer in the package insert. 2. In absence of explicit paediatric dose recommendations , an approximation can be made by methods based on age, weight or surface area. 3. Rules regarding this aren’t precise and should not be used if the manufacturer provides a paediatric dose. 4. When paediatric doses are calculated (either from one of the methods set forth below or from a manufacturers dose), the paediatric dose should never exceed the adult dose.
  • 21. Surface Area, Age, & Weight • Calculations of dosage based on age or weight are conservative and tend to underestimate the required dose. • Doses based on surface area are more likely to be adequate. Age (youngs formula) Dose = Adult dose x Age(years) Age+ 12
  • 22. Determination of drug dosage from surface area.
  • 23. • Weight ( Clarks rule): OR Dose =Adult dose x Weight (kg) 70 Dose = Adult dose x Weight (lb) 150
  • 24. Adverse drug reaction Children are growing and are more susceptible to adverse effects of drugs like 1. Corticosteroids – Suppression of growth 2. Androgens – Early fusion of epiphysis ( stunting of growth) 3. Tetracyclines - Discolouration & deformation of teeth 4. Phenothiazines - Dystonic reactions
  • 26. Duniya bhi ajab sara –e - faani dekhi Har cheez yahaa'n ki aani jaani dekhi Jo aa ke na jaaye wo budhaapa dekha Jo jaa ke na aaye wo jawaani dekhi Meer Babar Ali Anees World is like a mortal motel everything here is sure fatal (But) saw never ending oldhood and forever gone young puerile
  • 27. Pharmacologic changes Associated with aging Pharmacokinetics 1. Absorption Conditions associated with age that may alter the rate of absorption of drugs - 1. Altered nutritional habits 2. Greater consumption of non prescription drugs (eg, antacids and laxatives) 3. Changes in gastric emptying- slower in older persons (older diabetics)
  • 28. 2. Distribution Elderly have ( compared to young adults)  Reduced lean body mass  Reduced body water  ↑ fat as a percentage of body mass  ↓ serum albumin  ↑ serum orosomucoid (a-acid glycoprotein)  Loading dose - Alteration  Maintenance dose - Reduced because of reduced clearance of the drug.
  • 29. Effect on plasma protein binding Plasma protein binding reduced due to  Reduction in plasma albumin levels  Changes in binding affinity due to ageing. Dose should be ↓ ↓
  • 30. Drugs whose reduced protein binding in elderly leads to adverse reactions • Warfarin • Diazepam • Lorazepam • Phenytoin • Phenylbutazone • Tolbutamide
  • 31. Effects of Aging on Volume of Distribution (Vd) Aging Effect Vd Effect Examples  body water  Vd for hydrophilic drugs ethanol, lithium  lean body mass  Vd for for drugs that bind to muscle digoxin  fat stores  Vd for lipophilic drugs diazepam, trazodone  plasma protein (albumin)  % of unbound or free drug (active) diazepam, valproic acid, phenytoin, warfarin  plasma protein (1-acid glycoprotein)  % of unbound or free drug (active) quinidine, propranolol, erythromycin, amitriptyline
  • 32. • Examples: Water soluble drugs like digoxin: in elderly the Vd of digoxin is reduced so smaller dose in required to provide adequate digitalization. Lipid soluble drugs (lignocaine, thiopentone), Vd rises leading to increased half life of a drug: increase drug effect and toxicity. So dose should be reduced.
  • 33. 3. Metabolism 1. ↓ in hepatic microsomal drug metabolising activity 2. ↓ hepatic blood flow 3. Heart failure - Alter the ability of the liver to metabolize drugs - By Reducing hepatic blood flow.
  • 34. 3. Elimination • Age related decline of renal functional capacity is very important • Decline in creatinine clearance occurs in about two thirds of the population. • Serum creatinine alone is not an adequate measure of renal function. • Practical result  Marked prolongation - half-life of many drugs eg - atenolol, gabapentin, digoxin, quinolones, lithium, aminoglycosides.  Possibility of accumulation to toxic levels if dosage is not reduced in size or frequency.
  • 35. • Rough correction can be made by using Patients from ages 40 through 80: • For women, the result should be multiplied by 0.85 (because of reduced muscle mass). Creatinine clearance (mL/min) = (140 -Age) x (Weight in kg) 72 xSerum creatinine in mg/dL
  • 36. Lungs are important for the excretion of volatile drugs.  ↓ respiratory capacity  ↑ incidence of active pulmonary disease in the elderly Use of inhalation anaesthesia is less common and parenteral agents more common in this age group
  • 37. Pharmacodynamic Changes • It was long believed that geriatric patients were much more sensitive to the action of many drugs, implying a change in the pharmacodynamic interaction of the drugs with their receptors • Most apparent changes  Altered pharmacokinetics  Diminished homeostatic responses. • Some data from animal studies suggest actual changes with age in the characteristics or numbers of a few receptors. • The most extensive studies suggest a decrease in responsiveness to ß-adrenoceptor agonists.
  • 38. Diminished homeostatic responses are 1. Average blood pressure goes up - age Incidence of symptomatic orthostatic hypotension - Increases markedly. 2. Average 2- hour postprandial blood glucose level increases - 1 mg/dL for each year of age above 50. 3. Temperature regulation – impaired Hypothermia - Poorly tolerated by the elderly.
  • 39. Behavioral & Lifestyle Changes Forgetting to take ones pills Result of cognitive changes.
  • 40. Cns drugs Drugs to be avoided Reasons Safer alternatives a) Sedatives & hypnotics – antianxiety drugs -Diazepam -Barbiturates -Clorazepate -Prolongation of half life -highly sensitive leading to ataxia , loss of postural reflex and fall Oxazepam, lorazepam –do not form active metabolites -have short half life -less sedating b)Analgesics 1)Opioids Elderly very sensitive to respiratory depressant effects Pentazocine be avoided -Codeine , meperidine, morphine. -Titrate optimum dose and frequency of administration. 2)NSAIDs -Used very carefully may cause GIT bleeding and analgesic nephropathy -Indomethacin avoided due to CNS side effects. -Ibuprofen , nimesulide -Corticosteroids may be used along with calcium and Vit-D supplements.
  • 41. Cns drugs Drugs to be avoided Reasons Safer alternatives c)Antipsychotics -Phenothiazine analogues -Haloperidol analogues Avoided -greater risk of extrapyramidal side effects and postural hypotension -Elderly very sensitive to their anticholinergic side effects Thioridazine , olanzapine , risperidone , ziprasidone are safe. d) Antidepressants -Tricyclic antidepressants -due to postural hypotension & anticholinergic side effects -SSRIs -elimination not affected with ageing. e)Antimania -Lithium -Renal toxicity -carbamazepine or valproic acid.
  • 42. Cns drugs Drugs to be avoided Reasons Safer alternatives f) General anaesthetics -Halothane -Thiopental -more sensitive to halothane more prone to its hepatotoxicity -very sensitive to thiopental -midazolam , propofol -isoflurane - expensive g)Drugs for Alzheimer’s disease -Tacrine -sensitive to CNS toxicity having anti- cholinergic effects -hepatotoxicity -Donepezil , memantine , galantamine are preferred , being safer.
  • 43. CVS drugs Drugs to be avoided Reasons Safer alternatives a) Cardiac glycosides -Digoxin -increase sensitivity to toxic arrhythmogenic actions of digoxin -loading dose=reduced -maintenance dose=reduced. b) Antiarrhythmic drugs -Disopyramide -Quinidine -Quinidine clearance decreased and half life prolonged -Disopyramide avoided =its anti- muscarinic effects -dose must be reduced. c) Platelete inhibitors -Dipyridamole -postural hypotension, coronary steal -clopidogrel or aspirin
  • 44. Antihypertensive Drugs 1. Hypertension - Treated vigorously in the elderly. 2. Thiazides - First step in drug therapy 3. Hypokalemia , hyperglycemia, and hyperuricemia caused by these agents are more relevant in the elderly because of the higher incidence in these patients of arrhythmias, type 2 diabetes, and gout. 4. Calcium channel blockers – Effective and safe if titrated to the appropriate response Useful in patients who also have atherosclerotic angina. 5. Beta blockers - potentially hazardous in patients with obstructive airway disease - considered less useful than calcium channel blockers in older patients unless heart Failure is present.
  • 45. Drugs for Respiratory Diseases Drugs to be avoided Reasons Safer alternatives -Ephedrine -Isoproterenol -Theophylline -high BP, tachycardia -tremors -CNS stimulants -Salbutamol , beclomethasone Antibiotics Drugs to be avoided Reasons Safer alternatives -Penicillins -Cephalosporins -Fluoroquinolones -decline in renal function -sensitive to peripheral neuritis -Ceftriaxone or cefoperazone excreted through bile
  • 46. Anti-diabetic drugs Drugs to be avoided Reasons Safer alternatives -Chlorpropamide -Glibenclamide -half lives increased in elderly -serious hypoglycaemic episodes -fluid retention -Glipizide , gliclazide And natiglinide + metformin may be used
  • 47. Adverse drug reactions in elderly • Single drug – 10 % chances of ADR Ten drug – nearly 100 % chances of ADR • Patients may see several different practitioners for different conditions and accumulate multiple prescriptions for drugs with overlapping actions. • Reasons for high incidence of ADR include • Errors in prescribing on the part of the practitioner. • Errors in drug usage by the patient.
  • 48. Adverse drug reactions elderly • It is useful to Conduct a brown bag analysis in such patients. • Brown bag analysis consists of asking the patient to bring to the practitioner a bag containing all the medications, supplements, vitamins, etc, that he or she is currently taking
  • 49. Practical aspects of geriatric pharmacology • Quality of life in elderly patients can be greatly improved and life span can be prolonged by the intelligent use of drugs. • Expense of drugs can be a major disincentive in patients receiving marginal retirement incomes who are not covered or inadequately covered by health insurance. • Nonadherence may result from forgetfulness or confusion, especially if the patient has several prescriptions and different dosing intervals.
  • 50. Practical aspects of geriatric pharmacology • Prescriptions written by several Different practitioners - no attempt to design integrated regimens that use drugs with similar dosing Intervals for the conditions being treated. • Non adherence may also be deliberate. A decision not to take a drug may be based on prior experience with it.
  • 51. Errors in drug taking are caused by physical disabilities. 1. Arthritis 2. Tremor 3. Visual problems may all contribute. 4. Liquid medications that are to be measured by the spoonful are especially inappropriate for patients with any type of tremor or motor disability. Practical aspects of geriatric pharmacology
  • 52. • Cataracts and macular degeneration occur in a large number of patients over 70  Labels on prescription bottles should be large enough for the patient with diminished vision to read or  Colour coded if the patient can see but can no longer read Practical aspects of geriatric pharmacology
  • 53. Drug therapy has considerable potential for both helpful and harmful effects in the geriatric patient. The balance may be tipped in the right direction by adherence to a few principles: 1. Take a careful drug history. 2. Prescribe only for a specific and rational indication. Do not prescribe omeprazole for dyspepsia. 3. Define - Goal of drug therapy. 4. Maintain a high index of suspicion regarding drug reactions and interactions. 5. Simplify the regimen as much as possible.
  • 54. Conclusion Special caution should be taken while prescribing to paediatric and elderly age group taking in to consideration their altered pharmacokinetic and pharmacodynamics parameters Elderly patients are generally taking medicines for two or three associated chronic diseases (hypertension, diabetes , psychiatric illness etc) possibility of drug drug interaction should be given due attention while prescribing to them. Paediatric patients should not be treated as if they are mini adults ( simply modifying dose using body weight or surface area formula is not sufficient).
  • 55. References • Katzungs basic & clinical pharmacology 12th edition • Principle of pharmacology ,S.K Sharma 2nd edition • Pharmacology & pharmacotherapeutics, Satoskar 23rd edition
  • 57. B. Gastrointestinal Function • In full-term infants, gastric acid secretion begins soon after birth and increases gradually over Several hours. • In preterm infants, the secretion of gastric acid occurs more slowly, with the highest concentrations appearing on the fourth day of life. Therefore, drugs that are usually partially or totally inactivated by the low pH of gastric contents should not be administered orally. • Gastric emptying time is prolonged (up to 6 or 8 hours) in the first day or so after delivery - drugs absorbed primarily in stomach may be absorbed more completely than anticipated. • Drugs absorbed in the small intestine, therapeutic effect may be delayed • amount of drug absorbed in the small intestine - unpredictable; . Peristalsis in the neonate is irregular and may be slow. • more than the usual amount of drug may be absorbed if peristalsis is slowed, and this could result in potential toxicity from an otherwise standard dose.
  • 58. • An increase in peristalsis, as in diarrheal conditions, tends to decrease the extent of absorption, because contact time with the large absorptive surface of the intestine is decreased. • Gastrointestinal enzyme activities - lower in the newborn than in the adult. • Activities of a-amylase and other pancreatic enzymes in the duodenum are Low in infants up to 4 months Of age. • Neonates low concentrations of bile acids and lipase -decrease the absorption of lipid-soluble drugs.
  • 59. Paediatric dosage forms & compliance • Elixirs - alcoholic solutions - drug molecules are dissolved and evenly distributed. No shaking is required, and unless some of the vehicle has evaporated , the first dose from the bottle and the last dose should contain equivalent amounts of drug. • Suspensions - undissolved particles of drug that must be distributed throughout the vehicle by shaking. If shaking is not thorough each time a dose is given , the first doses from the bottle may contain less drug than the last doses, with the result that less than the expected plasma concentration or effect of the drug may be achieved early in the course of therapy. Conversely, Toxicity may occur late in the course of therapy , when it is not expected.
  • 60. • Uneven distribution is a potential cause of inefficacy or toxicity in children taking phenytoin suspensions . • Compliance may be more difficult to achieve in paediatric practice than otherwise, since it involves not only the parents conscientious effort to follow directions but also such practical matters as measuring errors , spilling, and spitting out. For example, the measured Volume of teaspoons ranges from2.5 to 7.8 mL . • Parents should obtain a calibrated medicine spoon or syringe from the pharmacy. These devices improve the accuracy of dose measurements and simplify administration of drugs to children.
  • 61. • Parents may not always be able to say with confidence how much of a dose the child actually received. • Parents must be told whether or not to wake the infant for its every- 6-hour dose day or night. • Matters should be discussed and made clear, and no assumptions should be made about what the parents may or may not do • Noncompliance frequently occurs when antibiotics are prescribed to treat otitis media or urinary tract infections and the child feels well after 4 or 5 days of therapy. • Parents may not feel there is any reason to continue giving the medicine even though it was prescribed for 10 or 14 days. This common situation should be anticipated so the parents can be told why it is important to continue giving the medicine for the prescribed period even if the child seems to be cured.・
  • 62. • Practical and convenient dosage forms and dosing schedules should be chosen to the extent possible. • Whenever a drug does not achieve its therapeutic effect, the possibility of noncompliance should be considered.
  • 63. Challenges of Geriatric Pharmacotherapy • New drugs available each year • Advanced understanding of drug-drug interactions • Multiple co-morbid states • Polypharmacy • Medication compliance • Effects of aging physiology on drug therapy • Medication cost
  • 64. Some potential strategies for the prevention or treatment of Alzheimer’s disease.
  • 65. Major drug groups CENTRAL NERVOUS SYSTEM DRUGS Sedatives & hypnotics • Half lives of many benzodiazepines and barbiturates increase by 50 - 150% between ages 30 and 70 change occurs during the decade from 60 to 70. • Toxicities of these drugs, ataxia and other signs of motor impairment should be particularly watched for in order to avoid accidents.
  • 66. Analgesics • Opioid analgesics show variable changes in pharmacokinetics with age. • Elderly - more sensitive to respiratory effects of these agents because of age-related changes in respiratory function.
  • 67. Antipsychotic & Antidepressant Drugs • Traditional antipsychotic agents (phenothiazines and haloperidol) Have been very heavily used (and probably misused) in the management of a variety of psychiatric diseases in the elderly.
  • 68. Drugs Used in Alzheimer’s Disease • Memantine binds to NMDA receptor channels in a use-dependent manner and produces a non competitive blockade. • Drug appears to be better tolerated and less Toxic than the cholinesterase inhibitors. • Memantine is available As Namenda in 5 and 10 mg oral tablets.
  • 69. • Positive Inotropic Agents 1. Heart failure is a common and particularly lethal disease in the elderly. 2. Toxic effects of digoxin - dangerous in the geriatric population- elderly are more susceptible to arrhythmias. 3. Because the drug is cleared mostly by the kidneys, renal function must be considered in designing a dosage regimen. 4. Hypokalemia, hypomagnesemia, hypoxemia (from pulmonary disease), and coronary atherosclerosis all contribute to the high incidence of digitalis-induced arrhythmias in geriatric patients.
  • 70. Antiarrhythmic Agents 1. Treatment of arrhythmias in the elderly is challenging because of the lack of good hemodynamic reserve. 2. The Frequency of electrolyte disturbances, and the high prevalence Of Severe coronary disease. 3. Clearances of quinidine and procainamide decrease and their half-lives increase with age. 4. Disopyramide should probably be avoided in the geriatric population because its major toxicities antimuscarinic action, 1. leading to voiding problems in men 2. negative inotropic cardiac effects, leading to heart failure 5. Measures (such as anticoagulant drugs) should be taken to reduce the risk of thromboembolism in chronic atrial fibrillation.
  • 71. Antimicrobial drugs • Age-related changes contribute to the high incidence of infections in geriatric patients. • In lungs, a major age and tobacco dependent decrease in mucociliary clearance significantly increases susceptibility to infection. • In urinary tract, the incidence of serious infection is greatly increased by urinary retention and catheterization in men. • Decreased renal function; because most of the ß-lactam, aminoglycoside, and fluoroquinolone antibiotics are excreted by this route, important changes in half-life may be expected. • Aminoglycosides cause concentration- and time-dependent toxicity in the kidney and in other organs.
  • 72. Anti-inflammatory drugs • Osteoarthritis is a very common disease of the elderly. • Nonsteroidal anti-inflammatory agents (NSAIDs) - used with special care in geriatric patients because they cause toxicities to which the elderly are very susceptible. • Aspirin - gastrointestinal irritation and bleeding. • Newer NSAIDs - renal damage may be irreversible. • Corticosteroids are extremely useful in elderly patients who cannot tolerate full doses of NSAIDs - but they consistently cause a dose- and duration- related increase in osteoporosis.
  • 73. Ophthalmic drugs Macular Degeneration • Age-related macular degeneration (AMD) is the most common cause of blindness in the elderly in the developed world.